VivoSim Labs, Inc.
VIVS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$826.26K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $826,263.00 |
|---|---|
| Enterprise Value | $-527,737.00 |
| Earnings per Share | $-5.35 |
| Beta | 1.49 |
| Outstanding Shares | 5,239,462 |
Return
| Return on Equity | 525.92% |
|---|---|
| Return on Assets | -320.72% |
| Return on Invested Capital | -729.02% |
Valuation & Multiples
| P/E Ratio | -0.03 |
|---|---|
| PEG | 0.06 |
| Price to Sales | - |
| Price to Book Ratio | -0.16 |
| Enterprise Value to Revenue | 20.7 |
| Enterprise Value to EBIT | -0.16 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | -0.13 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.97%▼ 1.81% |
|---|---|
| Total Invested | $109,707▼ 21.63% |
| Investors Holding | 24▲ 1.00% |
About Organovo Holdings Inc
15 employees
CEO: Keith Murphy
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicolo...